×
About 2,226 results

ALLMedicine™ Metabolic Alkalosis Center

Research & Reviews  607 results

Hypokalemic metabolic alkalosis in an adolescent female: Questions.
https://doi.org/10.1007/s00467-021-04984-2
Pediatric Nephrology (Berlin, Germany); Benderlioğlu E, Öğütlü H et. al.

Feb 23rd, 2021 - Hypokalemic metabolic alkalosis in an adolescent female: Questions.|2021|Benderlioğlu E,Öğütlü H,Akman AÖ,Taş D,Kuruç AI,|

Diagnosis and management of Bartter syndrome: executive summary of the consensus and re...
https://doi.org/10.1016/j.kint.2020.10.035
Kidney International; Konrad M, Nijenhuis T et. al.

Jan 29th, 2021 - Bartter syndrome is a rare inherited salt-losing renal tubular disorder characterized by secondary hyperaldosteronism with hypokalemic and hypochloremic metabolic alkalosis and low to normal blood pressure. The primary pathogenic mechanism is defe...

Quadriplegia and rhabdomyolysis as a presenting feature of Conn's syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839919
BMJ Case Reports; Kollipara S, Ravindra S et. al.

Jan 26th, 2021 - Conn's syndrome is an important endocrine cause for secondary hypertension. Hypokalaemia paralysis and rhabdomyolysis with accelerated hypertension may be the presenting symptoms of Conn's syndrome. Here, we present one such case of a 38-year-old ...

Novel SLC12A3 mutation in Gitelman syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813350
BMJ Case Reports; Veríssimo R, Leite de Sousa L et. al.

Jan 19th, 2021 - Gitelman syndrome (GS) is an autosomal recessive disease characterised by the presence of hypokalaemic metabolic alkalosis with hypomagnesaemia and hypocalciuria. The prevalence of this disease is 1-10/40 000. GS is usually associated with mild an...

see more →

Guidelines  2 results

Diagnosis and management of Bartter syndrome: executive summary of the consensus and re...
https://doi.org/10.1016/j.kint.2020.10.035
Kidney International; Konrad M, Nijenhuis T et. al.

Jan 29th, 2021 - Bartter syndrome is a rare inherited salt-losing renal tubular disorder characterized by secondary hyperaldosteronism with hypokalemic and hypochloremic metabolic alkalosis and low to normal blood pressure. The primary pathogenic mechanism is defe...

Dietary Chloride Deficiency Syndrome: Pathophysiology, History, and Systematic Literature Review
https://pubmed.ncbi.nlm.nih.gov/33182508/
Nutrients Signorelli GC, Bianchetti MG et. al.

Metabolic alkalosis may develop as a consequence of urinary chloride (and sodium) wasting, excessive loss of salt in the sweat, or intestinal chloride wasting, among other causes. There is also a likely underrecognized association between poor sal...

see more →

Drugs  491 results see all →

Clinicaltrials.gov  1,115 results

Potassium chloride - potassium chloride capsule, extended release-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=926e05bf-7f26-4817-a28f-422f7e2e1510

Feb 28th, 2021 - Potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic d...

Potassium chloride - potassium chloride tablet, film coated, extended release-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=104f2111-1a4b-48db-9493-5d36b5db5627

Feb 25th, 2021 - Potassium chloride extended-release tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insuffi...

Potassium chloride - potassium chloride tablet, film coated, extended release-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16c775e4-0dd8-4e9f-b2bf-dd2b639374cf

Feb 25th, 2021 - Potassium chloride extended-release tablets are indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insuffi...

Potassium chloride - potassium chloride solution-Lohxa
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=843a7b4e-e549-4f29-8f1a-60671617a0c0

Feb 24th, 2021 - Potassium chloride is indicated for the treatment and prophylaxis of hypokalemia in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. Potassium chloride is a potassium salt indicated for th...

Hypokalemic metabolic alkalosis in an adolescent female: Questions.
https://doi.org/10.1007/s00467-021-04984-2
Pediatric Nephrology (Berlin, Germany); Benderlioğlu E, Öğütlü H et. al.

Feb 23rd, 2021 - Hypokalemic metabolic alkalosis in an adolescent female: Questions.|2021|Benderlioğlu E,Öğütlü H,Akman AÖ,Taş D,Kuruç AI,|

see more →

News  11 results

A 5-Week-Old Boy With Progressive Nonbilious Vomiting: Osmosis USMLE Study Question
https://www.medscape.com/viewarticle/879904_2

Jun 22nd, 2017 - Answer: C. Hypochloremic hypokalemic metabolic alkalosis Infantile hypertrophic pyloric stenosis classically presents with progressive nonbilious projectile emesis and an enlarged pylorus (described as an "olive") upon abdominal examination. Prolo...

Acetazolamide doesn’t reduce duration of mechanical ventilation
https://www.mdedge.com/pulmonary-health-hub/article/106242/pulmonology/acetazolamide-doesnt-reduce-duration-mechanical
Mary Ann Moon

Feb 2nd, 2016 - Acetazolamide failed to reduce the duration of invasive mechanical ventilation in chronic obstructive pulmonary disease (COPD) patients who had pure or mixed metabolic alkalosis, according to results from a clinical trial published online Feb. 2 i.

Acetazolamide Fails to Reduce COPD Ventilation Time
https://www.medpagetoday.com/pulmonology/smokingcopd/55963

Feb 2nd, 2016 - Action Points Treatment with acetazolamide (Diamox) did not significantly reduce invasive mechanical ventilation times among hospitalized patients with chronic obstructive pulmonary disease and metabolic alkalosis, but the drug may still benefit t...

COPD Drug Does Not Significantly Reduce Ventilator Time
https://www.staging.medscape.com/viewarticle/858184

Feb 1st, 2016 - Acetazolamide, a drug that has been commonly used for chronic obstructive pulmonary disease (COPD), does not significantly reduce time on a ventilator for patients with the disease and metabolic alkalosis, new data show. However, the difference be...

COPD Drug Does Not Significantly Reduce Ventilator Time
https://www.medscape.com/viewarticle/858184

Feb 1st, 2016 - Acetazolamide, a drug that has been commonly used for chronic obstructive pulmonary disease (COPD), does not significantly reduce time on a ventilator for patients with the disease and metabolic alkalosis, new data show. However, the difference be...

see more →